Cyclomedica Australia Pty Ltd – Trademark Portfolio
Entity Type: 99
Cyclomedica Australia Pty Ltd holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 6 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 4 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include GALLIGAS, PULMOTEC, TECHNEGAS, ULTRALUTE, and RESPIRISCINT. The owner is based in Lucas Heights.
New Illawarra Road
Building 75, Business & Technology Park
Lucas Heights NSW2234 , AU
Showing of trademarks Trademarks
Trademark Classifications
Cyclomedica Australia Pty Ltd's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Cyclomedica Australia Pty Ltd have?
Cyclomedica Australia Pty Ltd has 9 U.S. trademarks filed with the USPTO. Of these, 6 registered, 2 abandoned.
What trademark classes does Cyclomedica Australia Pty Ltd file in?
Cyclomedica Australia Pty Ltd files trademarks across 4 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 1 (Chemicals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Cyclomedica Australia Pty Ltd's most well-known trademarks?
Cyclomedica Australia Pty Ltd's registered trademark portfolio includes well-known marks such as GALLIGAS, PULMOTEC, TECHNEGAS, ULTRALUTE, and RESPIRISCINT. These are among 6 currently registered trademarks in the portfolio.
What is Cyclomedica Australia Pty Ltd's trademark registration success rate?
Cyclomedica Australia Pty Ltd has a 75% trademark registration rate, with 6 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.